Medicaid claims from 2008 to 2016 indicate low rates of genetic testing among children with intellectual disability and autism spectrum disorder
The results suggest that the clinical implementation of genetic testing in children with neurodevelopmental disabilities in the Medicaid-enrolled population was low in frequency compared with the eligible population with neurodevelopmental disorders. Further research could identify facilitators and barriers to the clinical use of genetic testing in this population.
Authors
- Julián A. Martínez-Agosto (ORCID: https://orcid.org/0000-0001-6776-6949)
- Audrey Thurm
- Jonas Ventimiglia (ORCID: https://orcid.org/0009-0003-7901-7306)
- Victoria Yuan (ORCID: https://orcid.org/0009-0007-3971-9345)
- Lindsay Shea (ORCID: https://orcid.org/0000-0003-0610-0355)
- Tashalee Rushell Brown (ORCID: https://orcid.org/0000-0002-2367-8821)
- Tess Levy (ORCID: https://orcid.org/0000-0003-2207-0440)
- Wei-Lin Lee (ORCID: https://orcid.org/0000-0003-2353-5596)
Institutions
- University of California, Los Angeles (US)
- Neurobehavioral Systems (US)
- National Institute of Mental Health (US)
- National Institute of Mental Health (CZ)
- Drexel University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Genetics in Medicine
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1016/j.gim.2025.101451
- Citations
- 4
- Primary Topic
- Autism Spectrum Disorder Research
- Type
- article
- Field-Weighted Citation Impact
- 5.72
Funders
- U.S. Department of Health and Human Services
- American Academy of Child and Adolescent Psychiatry
- National Institutes of Health
- Centers for Disease Control and Prevention
- Health Resources and Services Administration
- National Institute of Mental Health
- National Center on Birth Defects and Developmental Disabilities